Bird Flu

Carrington Subsidiary DelSite Enters Into Consulting Agreement with Biologics Consulting Groups, Inc.

Published in Vaccine Weekly, July 25th, 2007

Carrington Laboratories, Inc. (NASDAQ:CARN) announced its wholly-owned subsidiary, DelSite Biotechnologies, Inc., and Biologics Consulting Group, Inc. of Alexandria, Virginia, entered into a consulting agreement for regulatory and product development advice with the H5N1 bird influenza vaccine.

Biologics Consulting Group, Inc. (BCG) is a team of consultant experts who provide regulatory and product development advice on the development and commercial production of biotechnological and biologics products.

BCG's staff consists of experts in regulatory affairs, product manufacturing and testing, pharmacology/toxicology, facility inspections, statistics,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2007-07-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry